BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23635670)

  • 21. Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
    Scime NV; Brown HK; Metcalfe A; Simpson AN; Brennand EA
    Am J Obstet Gynecol; 2023 Dec; 229(6):658.e1-658.e17. PubMed ID: 37544349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women.
    Chen IJ; Shoupe D; Karim R; Stanczyk FZ; Kono N; Sriprasert I; Hodis HN; Mack WJ
    Menopause; 2023 Jul; 30(7):692-702. PubMed ID: 37192828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.
    Parker WH; Broder MS; Chang E; Feskanich D; Farquhar C; Liu Z; Shoupe D; Berek JS; Hankinson S; Manson JE
    Obstet Gynecol; 2009 May; 113(5):1027-1037. PubMed ID: 19384117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inappropriate oophorectomy at time of benign premenopausal hysterectomy.
    Mahal AS; Rhoads KF; Elliott CS; Sokol ER
    Menopause; 2017 Aug; 24(8):947-953. PubMed ID: 28486247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy.
    Progetto Menopausa Italia Study Group
    Maturitas; 2000 Jul; 36(1):19-25. PubMed ID: 10989238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
    Assaf W; Andraous M; Lavie O; Segev Y
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of secondary ovarian lesions after hysterectomy without oophorectomy versus unilateral oophorectomy for benign conditions: a retrospective analysis of patients during a nine-year period of observation.
    Baloglu A; Bezircioglu I; Cetinkaya B; Karci L; Bicer M
    Clin Exp Obstet Gynecol; 2010; 37(4):299-302. PubMed ID: 21355462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
    Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
    Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer.
    Matsuo K; Machida H; Shoupe D; Melamed A; Muderspach LI; Roman LD; Wright JD
    Obstet Gynecol; 2016 Oct; 128(4):761-70. PubMed ID: 27607873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
    Hickey M; Ambekar M; Hammond I
    Hum Reprod Update; 2010; 16(2):131-41. PubMed ID: 19793841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate of Oophorectomy for Benign Indications in a Children's Hospital: Influence of a Gynecologist.
    Trotman GE; Cheung H; Tefera EA; Darolia R; Gomez-Lobo V
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):234-238. PubMed ID: 27769688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: a cohort study.
    Laughlin-Tommaso SK; Satish A; Khan Z; Smith CY; Rocca WA; Stewart EA
    Menopause; 2020 Jan; 27(1):33-42. PubMed ID: 31479034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian conservation versus bilateral oophorectomy at the time of hysterectomy for benign disease.
    Parker WH
    Menopause; 2014 Feb; 21(2):192-4. PubMed ID: 23880797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
    Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer.
    Mandelbaum RS; Chen L; Shoupe D; Paulson RJ; Roman LD; Wright JD; Matsuo K
    Gynecol Oncol; 2019 Jul; 154(1):45-52. PubMed ID: 31036348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic oophorectomy in ovarian cancer prevention.
    Kontoravdis A; Kalogirou D; Antoniou G; Kontoravdis N; Karakitsos P; Zourlas PA
    Int J Gynaecol Obstet; 1996 Sep; 54(3):257-62. PubMed ID: 8889634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian conservation at the time of hysterectomy for benign disease.
    Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
    Clin Obstet Gynecol; 2007 Jun; 50(2):354-61. PubMed ID: 17513923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Oophorectomy and Fat and Lean Body Mass: Evidence from a Population-Based Sample of U.S. Women.
    Karia PS; Joshu CE; Visvanathan K
    Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1424-1432. PubMed ID: 33879451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of ovarian pathology after hysterectomy without oophorectomy.
    Plöckinger B; Kölbl H
    J Am Coll Surg; 1994 Jun; 178(6):581-5. PubMed ID: 8193751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility preservation in young women with epithelial ovarian cancer.
    Wright JD; Shah M; Mathew L; Burke WM; Culhane J; Goldman N; Schiff PB; Herzog TJ
    Cancer; 2009 Sep; 115(18):4118-26. PubMed ID: 19670446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.